Optimizing the management of congenital thrombotic thrombocytopenic purpura. [PDF]
Glasner MF +4 more
europepmc +1 more source
Unintended Interruption of Caplacizumab Therapy Can Compromise Outcomes in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Lessons from Two Clinical Cases. [PDF]
Özcan F +5 more
europepmc +1 more source
Thrombotic Microangiopathy Presenting With Multisystem Involvement and Acute Neurologic Deficits in a 61-Year-Old Female: A Case of Acquired Thrombotic Thrombocytopenic Purpura. [PDF]
Verhaegh T +5 more
europepmc +1 more source
N-Acetylcysteine Therapy in Thrombotic Thrombocytopenic Purpura: A Systematic Review and Critical Appraisal. [PDF]
Demirci U, Bilgin ZT, Baysal M.
europepmc +1 more source
Thrombotic thrombocytopenic purpura as a complication of pembrolizumab: a case report and literature Review. [PDF]
Palega G +3 more
europepmc +1 more source
Idiopathic thrombotic thrombocytopenic purpura
Carmen Garrido Arce +4 more
doaj
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies [PDF]
Essentials An international collaboration provides a consensus for clinical definitions. This concerns thrombotic microangiopathies and thrombotic thrombocytopenic purpura (TTP).
Flora Peyvandi +2 more
exaly +4 more sources
Related searches:
Thrombotic Thrombocytopenic Purpura
Pediatric Emergency Care, 2011In 1924, Dr Eli Moschcowitz described a 16-year-old adolescent girl with abrupt onset of petechiae, hemolytic anemia, followed by paralysis, coma, and death. Autopsy showed widespread hyaline thrombi in the terminal arterioles and capillaries of various organs. The syndrome described by Moschowitz is now known as thrombotic thrombocytopenic purpura.
Alex, Koyfman +2 more
openaire +2 more sources
Thrombotic Thrombocytopenic Purpura
Acta Medica Scandinavica, 1952Abstract 1.1. The clinical and pathologic observations of two cases of thrombotic thrombocytopenic purpura are presented. 2.2. This condition is characterized by the clinical triad of (1) hemolytic anemia; (2) thrombocytopenic purpura and (3) mental and neurologic abnormalities which may be bizarre or transient.
F, RACKOW, L, STEINGOLD, J H F, WOOD
openaire +4 more sources

